Taking Tally Of Office Depot, Inc. (ODP), AcelRx Pharmaceuticals, Inc. (ACRX)

The shares of Office Depot, Inc. have decreased by more than -25.99% this year alone. The shares recently went down by -2.96% or -$0.08 and now trades at $2.62. The shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), has jumped by 45.68% year to date as of 07/12/2018. The shares currently trade at $2.95 and have been able to report a change of -20.27% over the past one week.

The stock of Office Depot, Inc. and AcelRx Pharmaceuticals, Inc. were two of the most active stocks on Thursday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. ODP has an EBITDA margin of 5.01%, this implies that the underlying business of ODP is more profitable. The ROI of ODP is 3.10% while that of ACRX is -5.90%. These figures suggest that ODP ventures generate a higher ROI than that of ACRX.

Cash Flow

The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, ODP’s free cash flow per share is a positive 1.53, while that of ACRX is negative -0.1.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for ODP is 1.40 and that of ACRX is 4.00. This implies that it is easier for ODP to cover its immediate obligations over the next 12 months than ACRX.


ODP currently trades at a forward P/E of 7.66, a P/B of 0.67, and a P/S of 0.14 while ACRX trades at a P/S of 29.11. This means that looking at the earnings, book values and sales basis, ODP is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of ODP is currently at a -9.97% to its one-year price target of 2.91. Looking at its rival pricing, ACRX is at a -42.5% relative to its price target of 5.13.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), ODP is given a 3.00 while 2.40 placed for ACRX. This means that analysts are more bullish on the outlook for ODP stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for ODP is 3.17 while that of ACRX is just 5.16. This means that analysts are more bullish on the forecast for ODP stock.


The stock of Office Depot, Inc. defeats that of AcelRx Pharmaceuticals, Inc. when the two are compared, with ODP taking 6 out of the total factors that were been considered. ODP happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, ODP is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for ODP is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

A Side-by-side Analysis of Avinger, Inc. (AVGR) an...   Avinger, Inc. (NASDAQ:AVGR) shares are down more than -81.87% this year and recently increased 2.33% or $0.03 to settle at $1.32. Onconova T...
A Comparison of Top Movers: Bed Bath & Beyond... The shares of Bed Bath & Beyond Inc. have decreased by more than -8.23% this year alone. The shares recently went up by 0.70% or $0.14 and now tr...
Should You Buy Seattle Genetics, Inc. (SGEN) or In... Seattle Genetics, Inc. (NASDAQ:SGEN) shares are down more than -0.09% this year and recently increased 1.69% or $0.89 to settle at $53.45. Insmed Inco...
Whiting Petroleum Corporation (WLL) vs. The Chemou... Whiting Petroleum Corporation (NYSE:WLL) shares are down more than -10.61% this year and recently decreased -0.80% or -$0.19 to settle at $23.67. The ...
Comparing Valuation And Performance: Intel Corpora... The shares of Intel Corporation have increased by more than 17.96% this year alone. The shares recently went up by 0.24% or $0.13 and now trades at $5...